These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients. Ong YL; Deore R; El-Agnaf M Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e151-7. PubMed ID: 19016918 [TBL] [Abstract][Full Text] [Related]
4. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia]. Mödder B; Meuthen I Dtsch Med Wochenschr; 1986 Feb; 111(9):329-32. PubMed ID: 3948731 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera. Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599 [TBL] [Abstract][Full Text] [Related]
6. [Must we always treat hyperkalaemia?]. Basile C; Manobianca G; Bruno A; Tamma F G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832444 [TBL] [Abstract][Full Text] [Related]
7. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569 [TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera. Johansson P; Andréasson B Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960 [TBL] [Abstract][Full Text] [Related]
9. [Fibrinolysis studied by an in vitro clot lysis test in polycythemia vera]. Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M Orv Hetil; 1996 Jan; 137(2):71-4. PubMed ID: 8721871 [TBL] [Abstract][Full Text] [Related]
10. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T; Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279 [TBL] [Abstract][Full Text] [Related]
11. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481 [TBL] [Abstract][Full Text] [Related]
12. Elevated plasma levels of basic fibroblast growth factor in patients with essential thrombocythaemia and polycythaemia vera. Wehmeier A; Südhoff T Br J Haematol; 1997 Sep; 98(4):1050-1. PubMed ID: 9326212 [No Abstract] [Full Text] [Related]
13. [Therapeutic effect of ranimustine (MCNU) on essential thrombocythemia and polycythemia vera]. Nagai M; Tasaka T; Kamano H; Ohnishi H; Taoka T; Ikeda K; Kubota Y; Tanaka T; Irino S Gan To Kagaku Ryoho; 1988 Dec; 15(12):3267-70. PubMed ID: 3196045 [TBL] [Abstract][Full Text] [Related]
14. Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia. Farrukh F; Guglielmelli P; Loscocco GG; Pardanani A; Hanson CA; De Stefano V; Barbui T; Gangat N; Vannucchi AM; Tefferi A Am J Hematol; 2022 Feb; 97(2):E35-E37. PubMed ID: 34822188 [No Abstract] [Full Text] [Related]
15. [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses]. Linkesch W; Gisslinger H; Ludwig H; Flener R; Sinzinger H Acta Med Austriaca; 1985; 12(5):123-7. PubMed ID: 3914173 [TBL] [Abstract][Full Text] [Related]
16. Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia. Howard MR; Ashwell S; Bond LR; Holbrook I J Clin Pathol; 2000 Feb; 53(2):105-9. PubMed ID: 10767824 [TBL] [Abstract][Full Text] [Related]
17. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171 [TBL] [Abstract][Full Text] [Related]
18. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases. Kabutomori O; Kanakura Y; Iwatani Y Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783 [TBL] [Abstract][Full Text] [Related]